Nicotine stimulated bone marrow-derived dendritic cells could augment HBV specific CTL priming by activating PI3K-Akt pathway

Immunology Letters

Volumn 146, Issue 1-2, 2012, Pages 40-49

  Jin, Hao Jie ^a   Li, Hai Tao ^a   Sui, Hua Xiu ^a   Xue, Mao Qiang ^a   Wang, Yi Nan ^a   Wang, Jia Xun ^a   Gao, Feng Guang ^a,b  

^a XIAMEN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Dendritic cells; HBV; Immunotherapy; Nicotine; Vaccination

Indexed keywords

BUNGAROTOXIN RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 12; NICOTINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL STIMULATION; CELL TRANSFER; CONTROLLED STUDY; CTL PRIMING; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG EFFICACY; ENZYME ACTIVATION; FEMALE; FLOW CYTOMETRY; HEPATITIS B VIRUS; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION; WESTERN BLOTTING;

ADOPTIVE TRANSFER; ANIMALS; BONE MARROW CELLS; CELL LINE; CELL PROLIFERATION; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MICE; NICOTINE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

EID: 84864131595     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2012.02.015     Document Type: Article

References (46)

1. Stramer S.L., Wend U., Candotti D., Foster G.A., Hollinge F.B., Dodd R.Y., et al. Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med 2011, 364:236-247.
2. Lui G., Manches O., Angel J., Molens J.P., Chaperot L., Plumas J. Plasmacytoid dendritic cells capture and cross-present viral antigens from influenza-virus exposed cells. PLoS ONE 2009, 4:e7111.
3. Op den Brouw M.L., Binda R.S., Geijtenbeek T.B., Janssen H.L., Woltman A.M. The mannose receptor acts as hepatitis B virus surface antigen receptor mediating interaction with intrahepatic dendritic cells. Virology 2009, 10(393(1)):84-90.
4. Truong P., Heydari S., Garidou L., McGavern D.B. Persistent viral infection elevates central nervous system MHC class I through chronic production of interferons. J Immunol 2009, 183:3895-3905.
5. Belz G., Mount A., Masson F. Dendritic cells in viral infections. Handb Exp Pharmacol 2009, 188:51-77.
6. Beckebaum S., Cicinnati V.R., Dworacki G., Müller-Berghaus J., Stolz D., Harnaha J., et al. Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol 2002, 104:138-150.
7. Ludewig B., Ehl S., Karrer U., Odermatt B., Hengartner H., Zinkernagel R.M. Dendritic cells efficiently induce protective antiviral immunity. J Virol 1998, 72:3812-3818.
8. van der Molen R.G., Sprengers D., Binda R.S., de Jong E.C., Niesters H.G., Kusters J.G., et al. Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 2004, 40:738-746.
9. Woltman A.M., Op den Brouw M.L., Biesta P.J., Shi C.C., Janssen H.L. Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function. PLoS ONE 2011, 6:e15324.
10. Duan X.Z., Zhuang H., Wang M., Li H.W., Liu J.C., Wang F.S. Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2). J Gastroenterol Hepatol 2005, 20:234-242.
11. Inchauspé G., Michel M.L. Vaccines and immunotherapies against hepatitis B and hepatitis C viruses. J Viral Hepat 2007, 14(Suppl.):97-103.
12. + T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol 2004, 78:5707-5719.
13. Bitner R.S., Nikkel A.L., Markosyan S., Otte S., Puttfarcken P., Gopalakrishnan M. Selective alpha7 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3beta and decreases tau phosphorylation in vivo. Brain Res 2009, 1265:65-74.
14. Mandavilli A. Nicotine fix. Nat Med 2004, 10:660-661.
15. Liu Q., Zhang J., Zhu H., Qin C., Chen Q., Zhao B. Dissecting the signaling pathway of nicotine-mediated neuroprotection in a mouse Alzheimer disease model. FASEB J 2007, 21:61-73.
16. Wessler I.K., Kirkpatrick C.J. The non-neuronal cholinergic system: an emerging drug target in the airways. Pulm Pharmacol Ther 2001, 14:423-434.
17. Furie M.B., Raffanello J.A., Gergel E.I., Lisinski T.J., Horb L.D. Extracts of smokeless tobacco induce pro-inflammatory changes in cultured human vascular endothelial cells. Immunopharmacology 2000, 47:13-23.
18. Totti N., McCusker K.T., Campbell E.J., Griffin G.L., Senior R.M. Nicotine is chemotactic for neutrophils and enhances neutrophil responsiveness to chemotactic peptides. Science 1984, 223:169-171.
19. Guinet E., Yoshida K., Nouri-Shirazi M. Nicotinic environment affects the differentiation and functional maturation of monocytes derived dendritic cells (DCs). Immunol Lett 2004, 95:45-55.
20. Vassallo R., Tamada K., Lau J.S., Kroening P.R., Chen L. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J Immunol 2005, 175:2684-2691.
21. Aicher A., Heeschen C., Mohanpt M., Cooke J.P., Zeiher A.M., Dimmeler S. Nicotine strongly activates dendritic cell-mediated adaptive immunity-potential role for progression of atherosclerotic lesions. Circulation 2003, 107:604-611.
22. Gao F.G., Wan D.F., Gu J.R. Ex vivo nicotine stimulation augments the efficacy of therapeutic bone marrow-derived dendritic cell vaccination. Clin Cancer Res 2007, 13:3706-3712.
23. Gao F.G., Li H.T., Li Z.J., Gu J.R. Nicotine stimulated dendritic cells could achieve anti-tumor effects in mouse lung and liver cancer. J Clin Immunol 2011, 31:80-88.
24. Shi M., Qian S., Chen W.W., Zhang H., Zhang B., Tang Z.R., et al. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro. Clin Exp Immunol 2007, 147:277-286.
25. + T cells in xenografted nude mice. J Immunol 2003, 170:1183-1190.
26. Akbar S.M., Yoshida O., Chen S., Cesar A.J., Abe M., Matsuura B., et al. Immune modulator and antiviral potential of dendritic cells pulsed with both hepatitis B surface antigen and core antigen for treating chronic HBV infection. Antivir Ther 2010, 15:887-895.
27. McGill J., Van Rooijen N., Legge K.L. IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8T cell survival during influenza virus infection. J Exp Med 2010, 207:521-534.
28. Mito K., Sugiura K., Ueda K., Hori T., Akazawa T., Yamate J., et al. IFN-gamma markedly cooperates with intratumoral dendritic cell vaccine in dog tumor models. Cancer Res 2010, 70:7093-7101.
29. Agaugué S., Marcenaro E., Ferranti B., Moretta L., Moretta A. Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. Blood 2008, 112:1776-1783.
30. Marrero M.B., Bencherif M. Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-κB. Brain Res 2009, 1256:1-7.
31. + T cell to a fully functional tumor killer cell. Cancer Res 2002, 62:6438-6441.
32. Farag M.M., Hoyler B., Encke J., Stremmel W., Weigand K. Dendritic cells can effectively be pulsed by HBVsvp and induce specific immune reactions in mice. Vaccine 2010, 29:200-206.
33. Guo G., Chen S., Zhang J., Luo L., Yu J., Dong H., et al. Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood. Vaccine 2005, 23:5225-5230.
34. Hsu F.J., Benike C., Fagnoni F., Liles T.M., Czerwinski D., Taidi B., et al. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996, 2:52-58.
35. Schuler G., Schuler-Thurner B., Steinman R.M. The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 2003, 15:138-147.
36. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421:384-388.
37. Nouri-Shirazi M., Guinet E. Evidence for the immunosuppressive role of nicotine on human dendritic cell functions. Immunology 2003, 109:365-373.
38. Powell J.T. Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med 1998, 3:21-28.
39. Shi F.D., Piao W.H., Kuo Y.P., Campagnolo D.I., Vollmer T.L., Lukas R.J. Nicotinic attenuation of central nervous system inflammation and autoimmunity. J Immunol 2009, 182:1730-1739.
40. Reise Sousa C. Dendritic cells in a mature age. Nat Rev Immunol 2006, 6:476-483.
41. Schoenfeld J., Jinushi M., Nakazaki Y., Wiener D., Park J., Soiffer R., et al. Active immunotherapy induces antibody responses that target tumor angiogenesis. Cancer Res 2010, 70:10150-10160.
42. Birkholz K., Schwenkert M., Kellner C., Gross S., Fey G., Schuler-Thurner B., et al. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation. Blood 2010, 116:2277-2285.
43. Paleari L., Catassi A., Ciarlo M., Cavalieri Z., Bruzzo C., Servent D., et al. Role of alpha7-nicotinic acetylcholine receptor in human non-small cell lung cancer proliferation. Cell Prolif 2008, 41:936-959.
44. Sun X., Ritzenthaler J.D., Zhong X., Zheng Y., Roman J., Han S. Nicotine stimulates PPARbeta/delta expression in human lung carcinoma cells through activation of PI3K/mTOR and suppression of AP-2alpha. Cancer Res 2009, 69:6445-6453.
45. Zhang Q., Tang X., Zhang Z.F., Velikina R., Shi S., Le A.D. Nicotine induces hypoxia-inducible factor-1alpha expression in human lung cancer cells via nicotinic acetylcholine receptor-mediated signaling pathways. Clin Cancer Res 2007, 13:4686-4694.
46. Mishra N.C., Rir-sima-ah J., Boyd R.T., Singh S.P., Gundavarapu S., Langley R.J., et al. Nicotine inhibits Fc epsilon RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha 7/alpha 9/alpha 10-nicotinic receptors. J Immunol 2010, 185:588-596.